X0508 4 2025-02-27 false 0001645113 NovoCure Ltd NVCR 0002039078 Paravasthu Mukund C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115 WAYNE PA 19087 false true false false Chief Operating Officer false Ordinary Shares 2025-02-27 4 S false 1379.00 19.9219 D 30058.00 D Ordinary Shares 2025-02-27 4 S false 267.00 20.549 D 29791.00 D Ordinary Shares 2025-02-28 4 S false 368.00 18.2843 D 29423.00 D On February 27, 2025, the reporting person sold 1,379 shares in multiple trades at prices ranging from $19.41 to $20.4033. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. On February 27, 2025, the reporting person sold 267 shares in multiple trades at prices ranging from $20.41 to $20.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. On February 28, 2025, the reporting person sold 368 shares in multiple trades at prices ranging from $18.175 to $18.765. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Steven Robbins, as attorney in fact for Paravasthu, Mukund 2025-03-03